Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.300
+0.020 (1.56%)
Jun 27, 2025, 4:00 PM - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $13.52 million as of June 27, 2025. Its market cap has decreased by -64.94% in one year.
Market Cap
13.52M
Enterprise Value
22.94M
1-Year Change
-64.94%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $13.52M, a decrease of -51.75%. That is a compound annual growth rate of -4.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| Novo Nordisk | 331.06B |
| AbbVie | 322.03B |
| UnitedHealth Group | 280.41B |
| Abbott Laboratories | 233.80B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |